Lonza Joins International Pharmaceutical Aerosol Consortium
Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies
Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies
An estimated 21 million American women experience BV
Yashoda Hospitals Hyderabad has earned the distinction of becoming the first to introduce BTVA in India
BVX-0922 to target colorectal cancer under investigator-sponsored IND
A major unresolved question in the field, however, is how do this machinery rapidly searches for and finds rare stretches of damage amid the "vast fields" of undamaged DNA
Approval is based on results of a multicenter, randomized, open-labeled and controlled IDE clinical study that demonstrated the superiority of Agili-C™ implant to the current surgical standard of care, debridement and microfracture in the knee joint
Ondexxya is the first approved reversal agent specifically for Factor Xa inhibitors, providing a major advance in the treatment of patients hospitalised with life-threatening bleeding
World-leading companies, as well as small innovative research groups, regularly partner with Medanex for their outstanding cardiovascular services and timely, efficacious study outcomes.
Ozempic is now approved in the US at 0.5 mg,1.0 mg and 2.0 mg doses for the treatment of type 2 diabetes in adults
Novel tool bypasses plasmid-based expression to increase stability and significantly reduce development time for a variety of synthetic biotechnology products
Subscribe To Our Newsletter & Stay Updated